CNR [CHINA METRO-RURAL] UPLOAD:
[]
CBPO [China Biologic Products] 8-K: (Original Filing)
[CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES ____________________________________________________________ 1. He is the duly elected and acting Chief Executive Officer of China Biologic Products, Inc., a Delaware corporation (the Corporation ). Board Preferred Stock ), of the Corporation designated as Series A Participating Preferred Stock: RESOLVED Charter ), the Board does hereby provide for the issuance of a series] [PREFERRED SHARES RIGHTS AGREEMENT Dated as of November 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION as Rights Agent TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 11 12 Section 6. Transfer, Split Up, Combination and Exchange] [CHINA BIOLOGIC PRODUCTS, INC. ADOPTS STOCKHOLDER RIGHTS PLAN The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to China Biologics stockholders. The plan does not prevent China Biologics] [FORM 8-K Current Report Date of Report (Date of earliest event reported): CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road 86-10-6698-3166 (Former name or address, if changed since last report) Item 1.01. Entry into a Material Definitive Agreement. On November 19, 2012, the Board]
CNET [ChinaNet Onlines,] 8-K: (Original Filing)
[exh_991.htm 2 EX-99.1]
CCM [Concord Medical Services] 6-K: (Original Filing)
[CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the Company) NOTICE OF ANNUAL GENERAL MEETING NOTICE (i) THAT the appointment of the Independent Auditor Ernst & Young Hua Ming for the fiscal year 2011 at a fee agreed by the directors be and is hereby ratified, confirmed, approved and adopted in all respects. (ii) THAT the appointment of the Independent Auditor Ernst &] [CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the Company) SHAREHOLDER PROXY , Meeting Name of third preference I/We, This form is to be used in respect of the resolutions mentioned below as follows: IN FAVOUR OF AGAINST Resolution 1 ¨ ¨ THAT the appointment of the Independent Auditor Ernst & Young Hua Ming for the fiscal year 2011 at a fee agreed] [TABLE OF CONTENTS EX-99.1 EX-99.2 TABLE OF CONTENTS CONCORD MEDICAL SERVICES HOLDINGS LIMITED]
BIDU [Baidu] 424B2: CALCULATION OF REGISTRATION FEE Title of Each Class
[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities To Be Registered Amount Proposed Offering Price Proposed Aggregate Amount of 2.250% Notes due 2017 US$750,000,000 99.929% US$749,467,500 US$102,227 3.500% Notes due 2022 US$750,000,000 99.849% US$748,867,500 US$102,146 (1) Prospectus Supplement (To Prospectus dated November 5, 2012) US$1,500,000,000 Baidu, Inc. US$750,000,000 2.250% Notes due 2017 US$750,000,000 3.500% Notes due 2022 We]
CBPO [China Biologic Products] 8-K: CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES
[CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES ____________________________________________________________ 1. He is the duly elected and acting Chief Executive Officer of China Biologic Products, Inc., a Delaware corporation (the Corporation ). Board Preferred Stock ), of the Corporation designated as Series A Participating Preferred Stock: RESOLVED Charter ), the Board does hereby provide for the issuance of a series] [PREFERRED SHARES RIGHTS AGREEMENT Dated as of November 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION as Rights Agent TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 11 12 Section 6. Transfer, Split Up, Combination and Exchange] [CHINA BIOLOGIC PRODUCTS, INC. ADOPTS STOCKHOLDER RIGHTS PLAN The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to China Biologics stockholders. The plan does not prevent China Biologics] [FORM 8-K Current Report Date of Report (Date of earliest event reported): CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road 86-10-6698-3166 (Former name or address, if changed since last report) Item 1.01. Entry into a Material Definitive Agreement. On November 19, 2012, the Board]
CNET [ChinaNet Onlines,] 8-K: exh_991.htm 2 EX-99.1
[exh_991.htm 2 EX-99.1]
CCM [Concord Medical Services] 6-K: CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the Company) NOTICE
[CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the Company) NOTICE OF ANNUAL GENERAL MEETING NOTICE (i) THAT the appointment of the Independent Auditor Ernst & Young Hua Ming for the fiscal year 2011 at a fee agreed by the directors be and is hereby ratified, confirmed, approved and adopted in all respects. (ii) THAT the appointment of the Independent Auditor Ernst &] [CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the Company) SHAREHOLDER PROXY , Meeting Name of third preference I/We, This form is to be used in respect of the resolutions mentioned below as follows: IN FAVOUR OF AGAINST Resolution 1 ¨ ¨ THAT the appointment of the Independent Auditor Ernst & Young Hua Ming for the fiscal year 2011 at a fee agreed] [TABLE OF CONTENTS EX-99.1 EX-99.2 TABLE OF CONTENTS CONCORD MEDICAL SERVICES HOLDINGS LIMITED]
BIDU [Baidu] 6-K: (Original Filing)
[Baidu Announces Pricing of US$1,500,000,000 Notes Offering The Company expects to receive net proceeds from the offering of approximately US$1,491.6 million, after deducting underwriting discounts and commissions and estimated net offering expenses. The Company intends to use a portion of the net proceeds from the offering to retire certain existing debt and the remainder for general corporate purposes. The joint] [BAIDU, INC. Robin Yanhong Li Chairman and Chief Executive Officer Description of Document]
CCM [Concord Medical Services] 6-K: (Original Filing)
[Concord Medical Reports Third Quarter 2012 Financial Results BEIJING, Nov. 21, 2012 Concord Medical Services Holdings Limited (Concord Medical or the Company) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Changan Hospital, today reported its unaudited consolidated financial results for] [TABLE OF CONTENTS EX-99.1 TABLE OF CONTENTS CONCORD MEDICAL SERVICES HOLDINGS LIMITED]
